Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease

501005, Concord

501004, Clayton

501003, Chermside West

501002, South Brisbane

501007, Birtinya

501008, Perth

423014, New York

423013, New York

423024, Manhasset

219001, Seongnam-si

423002, Philadelphia

423058, Philadelphia

423068, Washington D.C.

423060, Baltimore

423003, Baltimore

219005, Incheon

423012, Charlottesville

423039, Winston-Salem

423071, Chapel Hill

423017, Durham

423072, Charlotte

423045, Charleston

423001, Charleston

423027, Atlanta

423018, DeLand

423038, Vero Beach

423033, Tampa

423054, Tampa

423047, Tampa

423075, Bay Pines

423034, Kissimmee

423032, Birmingham

423067, Nashville

423079, Cleveland

423076, Indianapolis

423078, Ann Arbor

423029, Iowa City

423011, Milwaukee

423031, Rochester

219003, Gwangju

423008, St Louis

423015, Kansas City

423063, Wichita

423004, Omaha

423042, New Orleans

423065, Jefferson

423082, Oklahoma City

423005, Tyler

423081, Fort Worth

423037, Tucson

423069, San Francisco

423006, Stanford

423070, Sacramento

423007, Portland

423080, Edmonds

423074, Boston

423061, Boston

423009, Lebanon

501001, Greenslopes

215027, Tokyo

215007, Yamaguchi

219008, Seoul

215019, Aichi

215026, Aomori

215004, Fukuoka

215025, Fukuoka

215016, Fukuoka

215006, Gifu

215030, Hiroshima

215014, Hokkaido

215028, Ibaraki

215018, Ishikawa

215020, Ishikawa

215017, Kanagawa

215021, Kitakyushu

215009, Kyoto

215013, Kyoto

215022, Mie

215023, Nagano

215002, Niigata

215029, Osaka

215008, Osaka

215012, Osaka

215001, Tokyo

215005, Tokyo

215024, Tokyo

215003, Tokyo

215010, Wakayama

215011, Yokohama

219002, Seoul

219007, Seoul